ArticleFrontiers in oncology2017

Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells.

Marina Pifano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.